This doesn't refute anything col.
The support accelerated approval, but haven't yet given accelerated approval.
So they need another meeting, may get AA, then need to initiate another trial.
Which is what I've said about the results all along - interesting, but need further data.
This absolutely is in line with what I've been saying the whole time.
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-29
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |